Nifty

:

23727.65

Sensex

:

78472.87

-25.80 (-0.11%)
-67.30 (-0.09%)

Login

Nifty
Sensex

:
:

23727.65
78472.87

-25.80 (-0.11%)
-67.30 (-0.09%)

Alivus Life Sciences Ltd.

Pharmaceuticals & Drugs

Rating :

N/A

BSE: 543322 | NSE: GLS

Watchlist

NSE BSE

958.40

24-Dec-2024

Open
High
Low
Previous Close

994.00
998.70
955.00
993.90

Volume
Traded Value (lacs)
52 Week High
52 Week Low

131203
1267.65
1335.10
645.35

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

11,785.21
27.83
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

11,338.92
2.34%
4.64

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
8.23
2.45

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
7.39
1.82

PAT CAGR (%)

10 Years
5 Years
3 Years

-
8.50
3.99

P:E (Median)

8 Years
5 Years
3 Years

-
-
15.64

P:BV (Average)

8 Years
5 Years
3 Years

-
-
3.44

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
-
11.37

Earnings Forecasts:

Description 2024 2025 2026 2027
Adj EPS 38.43 40.6 48.36 57.36
P/E Ratio 28.18 26.67 22.39 18.88
Revenue 2283 2463 2816 3236
EBITDA 674 704 838 991
Net Income 471 489 577 650
ROA 17
P/Bk Ratio 5.69 4.96 4.32 3.82
ROE 21.07 18.66 18.53 18.33
FCFF 296.54 150.88 214.51 312.56
FCFF Yield 2.32 1.18 1.68 2.44

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 506.88 595.36 -14.86% 588.62 578.45 1.76% 536.60 621.32 -13.64% 572.80 540.73 5.93%
Expenses 372.52 428.28 -13.02% 429.13 385.29 11.38% 395.15 414.89 -4.76% 400.25 395.27 1.26%
EBITDA 134.36 167.08 -19.58% 159.48 193.16 -17.44% 141.45 206.43 -31.48% 172.56 145.46 18.63%
EBIDTM 26.51% 28.06% 27.09% 33.39% 26.36% 33.22% 30.12% 26.90%
Other Income 8.53 5.37 58.85% 5.49 1.85 196.76% 3.13 2.84 10.21% 1.69 6.61 -74.43%
Interest 0.34 0.40 -15.00% 0.35 0.40 -12.50% 0.36 0.12 200.00% 0.39 0.16 143.75%
Depreciation 15.09 13.13 14.93% 14.39 12.61 14.12% 14.53 11.52 26.13% 13.18 10.76 22.49%
PBT 127.46 158.93 -19.80% 150.24 182.00 -17.45% 129.68 197.63 -34.38% 160.68 141.14 13.84%
Tax 32.14 40.19 -20.03% 38.76 46.55 -16.73% 31.74 51.27 -38.09% 41.92 36.15 15.96%
PAT 95.32 118.74 -19.72% 111.48 135.45 -17.70% 97.94 146.36 -33.08% 118.77 104.99 13.13%
PATM 18.80% 19.94% 18.94% 23.42% 18.25% 23.56% 20.73% 19.42%
EPS 7.78 9.69 -19.71% 9.10 11.06 -17.72% 7.99 11.95 -33.14% 9.70 8.57 13.19%

Description Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var% Sep 23 Sep 22 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18
Net Sales 2,204.90 2,283.21 2,161.22 2,123.21 1,885.16 1,537.31 886.42 0.25 Net Sales Growth -5.61% 5.64% 1.79% 12.63% 22.63% 73.43% 354468.00% Cost Of Goods Sold 993.88 968.64 984.12 1,019.28 877.46 664.02 331.97 0.05 Gross Profit 1,211.02 1,314.58 1,177.10 1,103.93 1,007.70 873.29 554.45 0.20 GP Margin 54.92% 57.58% 54.46% 51.99% 53.45% 56.81% 62.55% 80.0% Total Expenditure 1,597.05 1,608.97 1,518.93 1,507.15 1,294.09 1,065.35 639.25 0.26 Power & Fuel Cost - 112.46 115.60 100.92 74.19 76.75 57.81 0.00 % Of Sales - 4.93% 5.35% 4.75% 3.94% 4.99% 6.52% 0% Employee Cost - 258.16 180.18 168.72 149.13 142.28 106.28 0.15 % Of Sales - 11.31% 8.34% 7.95% 7.91% 9.26% 11.99% 60.0% Manufacturing Exp. - 163.63 137.17 124.04 107.61 108.03 77.23 0.04 % Of Sales - 7.17% 6.35% 5.84% 5.71% 7.03% 8.71% 16.00% General & Admin Exp. - 55.14 46.45 54.18 43.36 44.09 29.51 0.02 % Of Sales - 2.42% 2.15% 2.55% 2.30% 2.87% 3.33% 8.00% Selling & Distn. Exp. - 38.52 45.10 31.78 33.79 26.32 27.91 0.00 % Of Sales - 1.69% 2.09% 1.50% 1.79% 1.71% 3.15% 0% Miscellaneous Exp. - 12.41 10.30 8.23 8.54 3.86 8.53 0.00 % Of Sales - 0.54% 0.48% 0.39% 0.45% 0.25% 0.96% 0% EBITDA 607.85 674.24 642.29 616.06 591.07 471.96 247.17 -0.01 EBITDA Margin 27.57% 29.53% 29.72% 29.02% 31.35% 30.70% 27.88% -4.00% Other Income 18.84 12.04 28.96 14.70 0.81 11.99 0.99 0.00 Interest 1.44 1.55 0.55 27.96 87.55 33.52 0.61 0.00 Depreciation 57.19 53.45 42.09 37.88 33.39 29.37 19.26 0.00 PBT 568.06 631.29 628.61 564.92 470.94 421.07 228.30 -0.01 Tax 144.56 160.40 161.65 146.20 119.36 107.97 32.70 0.42 Tax Rate 25.45% 25.41% 25.72% 25.88% 25.35% 25.64% 14.32% -4200.00% PAT 423.51 470.89 466.96 418.72 351.58 313.10 195.59 -0.43 PAT before Minority Interest 423.51 470.89 466.96 418.72 351.58 313.10 195.59 -0.43 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 19.21% 20.62% 21.61% 19.72% 18.65% 20.37% 22.07% -172.00% PAT Growth -16.23% 0.84% 11.52% 19.10% 12.29% 60.08% - EPS 34.57 38.44 38.12 34.18 28.70 25.56 15.97 -0.04

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18
Shareholder's Funds 2,332.32 2,138.21 2,054.31 752.75 401.69 88.13 -1.40 Share Capital 24.50 24.50 24.50 1.96 1.96 1.96 0.01 Total Reserves 2,296.76 2,107.02 2,026.31 750.79 399.73 86.17 -1.41 Non-Current Liabilities 756.95 67.40 32.70 22.89 16.45 6.86 0.00 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 693.40 7.87 0.00 0.00 0.00 0.00 0.00 Current Liabilities 438.77 1,014.89 746.80 1,444.93 1,307.46 1,380.41 1.48 Trade Payables 368.66 427.23 307.72 221.31 201.07 182.89 0.01 Other Current Liabilities 58.08 54.57 49.84 966.54 1,084.03 1,181.11 1.46 Short Term Borrowings 0.00 0.00 0.00 0.00 0.02 0.02 0.00 Short Term Provisions 12.03 533.09 389.24 257.08 22.34 16.40 0.01 Total Liabilities 3,528.04 3,220.50 2,833.81 2,220.57 1,725.60 1,475.40 0.08 Net Block 805.06 780.63 589.76 572.80 546.25 456.31 0.00 Gross Block 1,012.33 936.48 705.53 651.90 594.82 475.57 0.00 Accumulated Depreciation 207.26 155.85 115.77 79.10 48.58 19.26 0.00 Non Current Assets 1,612.05 851.81 706.42 598.03 565.49 544.70 0.00 Capital Work in Progress 105.99 61.62 96.95 14.10 10.73 80.39 0.00 Non Current Investment 0.08 0.08 0.08 0.08 0.08 0.08 0.00 Long Term Loans & Adv. 700.92 9.49 19.63 11.06 8.44 7.92 0.00 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 1,916.00 2,368.68 2,127.39 1,622.53 1,160.11 930.70 0.08 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 666.59 604.17 516.24 513.42 412.77 400.84 0.04 Sundry Debtors 765.43 806.77 673.49 619.50 638.63 448.09 0.03 Cash & Bank 301.59 309.40 512.16 115.60 10.00 2.06 0.01 Other Current Assets 182.38 71.72 5.96 70.31 98.71 79.70 0.01 Short Term Loans & Adv. 90.69 576.63 419.54 303.70 65.00 18.04 0.01 Net Current Assets 1,477.23 1,353.80 1,380.59 177.60 -147.35 -449.72 -1.40 Total Assets 3,528.05 3,220.49 2,833.81 2,220.56 1,725.60 1,475.40 0.08

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18
Cash From Operating Activity 413.51 306.01 597.59 388.11 195.01 10.35 -0.48 PBT 631.29 628.61 564.92 470.94 421.07 228.30 -0.01 Adjustment 79.27 44.62 70.99 133.31 56.74 -101.15 0.00 Changes in Working Capital -134.08 -213.66 99.84 -107.58 -190.26 -93.26 -0.47 Cash after chg. in Working capital 576.48 459.57 735.75 496.68 287.54 33.89 -0.48 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -162.96 -153.56 -138.17 -108.56 -92.54 -23.54 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -116.48 -146.75 -122.23 -68.73 -50.52 -8.91 0.00 Net Fixed Assets -120.22 -195.62 -136.48 -60.45 -49.59 -555.96 Net Investments 0.00 0.00 0.00 0.00 0.00 -0.08 Others 3.74 48.87 14.25 -8.28 -0.93 547.13 Cash from Financing Activity -279.44 -387.59 -78.80 -213.78 -136.55 0.54 0.49 Net Cash Inflow / Outflow 17.59 -228.33 396.56 105.60 7.94 1.97 0.01 Opening Cash & Equivalents 283.82 512.16 115.60 10.00 2.06 0.01 0.00 Closing Cash & Equivalent 301.41 283.82 512.16 115.60 10.00 2.06 0.01

Financial Ratios

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18
Book Value (Rs.) 189.45 173.97 167.38 69.83 37.26 449.62 -1398.00 ROA 13.96% 15.43% 16.57% 17.82% 19.56% 26.51% -510.59% ROE 21.15% 22.33% 29.87% 60.91% 127.84% 451.05% 0.00% ROCE 28.31% 30.01% 42.24% 96.75% 185.60% 527.74% 0.00% Fixed Asset Turnover 2.35 2.65 3.13 3.03 2.88 3.73 248.00 Receivable days 125.30 124.34 111.01 121.50 128.84 92.26 45.63 Inventory Days 101.28 94.11 88.40 89.45 96.46 82.54 55.93 Payable days 149.95 136.29 94.72 87.85 65.75 52.18 24.84 Cash Conversion Cycle 76.63 82.16 104.69 123.10 159.54 122.62 76.71 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 409.34 1150.19 21.20 6.38 13.56 378.35 0.00

Top Investors:

polar capital funds plc - healthcare opportunities

massachusetts institute of technology

quant mutual fund - quant flexi cap fund

Annual Reports:

News Update:

Glenmark Life Scienc - Quarterly Results
24th Oct 2024, 18:27 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback